title: Will nanomedicine deliver on its promise of changing therapeutics or remain an interesting and important research tool in cell biology and physiology?
authors.affiliation: Platform Technologies and Science, Research and Development, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA 19406, United States. RichardL.Kirsh@gsk.com
authors.forename: Richard
authors.initials: R
authors.lastname: Kirsh
authors.forename: Steve
authors.initials: S
authors.lastname: Hood
authors.forename: Chris
authors.initials: C
authors.lastname: Brook
authors.forename: Aidan
authors.initials: A
authors.lastname: Gilmartin
authors.forename: Philip
authors.initials: P
authors.lastname: Dell'orco
authors.forename: Tom
authors.initials: T
authors.lastname: Meek
mesh_terms: D000818:Animals; D035843:Biomedical Research / Q000639:trends*; D016503:Drug Delivery Systems / Q000639:trends*; D006801:Humans; D036103:Nanotechnology / Q000639:trends*; D013678:Technology, Pharmaceutical / Q000639:trends*